OA10121A - Steroidal glycosides for treating hypercholesterolemia - Google Patents
Steroidal glycosides for treating hypercholesterolemia Download PDFInfo
- Publication number
- OA10121A OA10121A OA60598A OA60598A OA10121A OA 10121 A OA10121 A OA 10121A OA 60598 A OA60598 A OA 60598A OA 60598 A OA60598 A OA 60598A OA 10121 A OA10121 A OA 10121A
- Authority
- OA
- OAPI
- Prior art keywords
- carbonyl
- cellobiosyl
- methylene
- alpha
- compound according
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J71/00—Steroids in which the cyclopenta(a)hydrophenanthrene skeleton is condensed with a heterocyclic ring
- C07J71/0005—Oxygen-containing hetero ring
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/58—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids containing heterocyclic rings, e.g. danazol, stanozolol, pancuronium or digitogenin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Cardiology (AREA)
- Obesity (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hematology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Steroid Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US90491492A | 1992-06-26 | 1992-06-26 |
Publications (1)
Publication Number | Publication Date |
---|---|
OA10121A true OA10121A (en) | 1996-12-18 |
Family
ID=25419965
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
OA60598A OA10121A (en) | 1992-06-26 | 1994-12-23 | Steroidal glycosides for treating hypercholesterolemia |
Country Status (19)
Country | Link |
---|---|
US (2) | US5629295A (fr) |
EP (4) | EP0796864A2 (fr) |
JP (2) | JPH07504921A (fr) |
KR (1) | KR950702203A (fr) |
CN (1) | CN1085561A (fr) |
AP (1) | AP489A (fr) |
AU (1) | AU4226593A (fr) |
BG (1) | BG99261A (fr) |
BR (1) | BR9306619A (fr) |
CA (1) | CA2139104A1 (fr) |
CZ (1) | CZ331094A3 (fr) |
HR (1) | HRP930994A2 (fr) |
IL (1) | IL106055A0 (fr) |
MX (1) | MX9303826A (fr) |
OA (1) | OA10121A (fr) |
RU (1) | RU94046294A (fr) |
SK (1) | SK158394A3 (fr) |
WO (1) | WO1994000480A1 (fr) |
YU (1) | YU44793A (fr) |
Families Citing this family (42)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO1994000478A1 (fr) * | 1992-06-26 | 1994-01-06 | Pfizer Inc. | PROCEDE DE SYNTHESE DE β-O-CELLOBIOSIDE HEPTAALCANOATE STEROIDIEN |
CA2161239A1 (fr) * | 1993-04-28 | 1994-11-10 | Douglas J.M. Allen | Spirostanyl-glycosidal monohydrate cristallise |
US5502038A (en) * | 1993-06-21 | 1996-03-26 | Medical Research Foundation Of Oregon | Cholesterol sequestrant glycosides that inhibit intestinal cholesterol absorption |
ES2074006B1 (es) * | 1993-07-05 | 1996-03-16 | Pfizer | Glicosidos esteroidales para tratar hipercolesterolemia. |
FI96243C (fi) * | 1993-10-26 | 1996-05-27 | Ilmari Paakkinen | Menetelmä ja laite rakeisten maamassojen ominaisuuksien mittaamiseksi |
JPH09500906A (ja) * | 1993-12-28 | 1997-01-28 | ファイザー・インク. | 血中コレステロール低下薬 |
EP0737203A1 (fr) * | 1993-12-28 | 1996-10-16 | Pfizer Inc. | Glycosides steroidiens |
FR2722690B1 (fr) * | 1994-07-21 | 1996-10-25 | Univ Montpellier Ii | Compositions de saponines et/ou de leurs formes aglycones et leurs applications comme medicaments |
PL318937A1 (en) * | 1994-08-30 | 1997-07-21 | Pfizer | Spirostanyloglycoside crystals |
MX9702175A (es) * | 1994-09-20 | 1997-06-28 | Pfizer | Combinacion de un inhibidor de absorcion de colesterol y un inhibidor de sintesis de colesterol. |
US6150336A (en) * | 1995-05-29 | 2000-11-21 | Pfizer Inc. | Steroidal glycosides |
US5698527A (en) * | 1995-08-08 | 1997-12-16 | Merck & Co., Inc. | Steroidal glycosides as antihyperlipidemic agents |
US5756470A (en) * | 1996-10-29 | 1998-05-26 | Schering Corporation | Sugar-substituted 2-azetidinones useful as hypocholesterolemic agents |
GB9923076D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
HUP0101693A3 (en) * | 1998-03-26 | 2002-08-28 | Phytopharm Plc Godmanchester | Use of steroidal sapogenins and their derivatives for producing pharmaceutical compositions for the treatment of alzheimeirs disease |
JP3370610B2 (ja) * | 1998-08-21 | 2003-01-27 | 武田薬品工業株式会社 | 害虫防除剤 |
US20030060425A1 (en) * | 1998-11-24 | 2003-03-27 | Ahlem Clarence N. | Immune modulation method using steroid compounds |
GB9923078D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
US6343258B1 (en) | 1999-08-13 | 2002-01-29 | ALEXIS Brian | Method for testing for readiness for harvesting of tribulus terrestris l. having high steroidal saponin content |
GB9923077D0 (en) * | 1999-09-29 | 1999-12-01 | Phytopharm Plc | Sapogenin derivatives and their use |
CA2389670A1 (fr) * | 1999-11-01 | 2001-05-10 | Forbes Medi-Tech Inc. | Nouveaux glycosides contenant des mono-, di-, tri- ou oligosaccharides pentose et des phytosterols et/ou des phytostanols |
GB0000228D0 (en) * | 2000-01-06 | 2000-03-01 | Phytopharm Plc | Fluoro substituted sapogenins and their use |
US6207638B1 (en) | 2000-02-23 | 2001-03-27 | Pacifichealth Laboratories, Inc. | Nutritional intervention composition for enhancing and extending satiety |
US6558690B2 (en) | 2000-12-15 | 2003-05-06 | Pacific Health Laboratories, Inc. | Nutritional composition for improving the efficacy of a lipase inhibitor |
US6429190B1 (en) | 2000-12-15 | 2002-08-06 | Pacifichealth Laboratories, Inc. | Method for extending the satiety of food by adding a nutritional composition designed to stimulate cholecystokinin(CCK) |
GB0107822D0 (en) * | 2001-03-28 | 2001-05-23 | Phytopharm Plc | Sapogenin derivatives their synthesis and use methods based upon their use |
US6703530B2 (en) * | 2002-02-28 | 2004-03-09 | General Electric Company | Chemical reactor system and process |
CN102727501A (zh) * | 2002-03-27 | 2012-10-17 | 菲特法姆股份有限公司 | 皂角苷配基及其衍生物的用途 |
US20050130948A1 (en) * | 2002-03-27 | 2005-06-16 | Daryl Rees | Therapeutic methods and uses of sapogenins and their derivatives |
ATE459636T1 (de) * | 2002-10-28 | 2010-03-15 | Phytopharm Plc | Stereospezifische reduktion von sapogen-3-onen |
EP1819681B1 (fr) | 2004-11-23 | 2009-08-12 | Warner-Lambert Company LLC | Derives d'acide 7-(2h-pyrazol-3-yl)-3, 5-dihyroxy-heptanoique comme inhibiteurs de hmg co-a reductase pour le traitement de l'hyperlipidemie |
US7741317B2 (en) | 2005-10-21 | 2010-06-22 | Bristol-Myers Squibb Company | LXR modulators |
US7888376B2 (en) | 2005-11-23 | 2011-02-15 | Bristol-Myers Squibb Company | Heterocyclic CETP inhibitors |
CN101663262B (zh) | 2006-12-01 | 2014-03-26 | 百时美施贵宝公司 | 用于治疗动脉粥样硬化和心血管疾病的作为cetp抑制剂的n-(3-苄基)-2,2-(二苯基)-丙-1胺衍生物 |
JP5564490B2 (ja) | 2008-04-18 | 2014-07-30 | リアタ ファーマシューティカルズ インコーポレイテッド | 抗炎症性ファルマコアを含む化合物および使用法 |
CA2731650A1 (fr) | 2008-07-22 | 2010-01-28 | Tadashi Honda | Cyanoenones monocycliques et leurs procedes d'utilisation |
US20130072519A1 (en) | 2010-05-21 | 2013-03-21 | Edward Lee Conn | 2-phenyl benzoylamides |
JP2014513923A (ja) | 2011-03-04 | 2014-06-19 | ファイザー・インク | Edn3様ペプチドおよびその使用 |
CU20110244A7 (es) * | 2011-12-27 | 2013-08-29 | Ct De Investigación Y Desarrollo De Medicamentos Cidem | Sistemas espiroesteroidales con efectos neuroactivos y anti-inflamatorios |
MX2015014666A (es) | 2013-04-17 | 2016-03-01 | Pfizer | Derivados de n-piperidin-3-ilbenzamida para tratar enfermedades cardiovasculares. |
WO2016055901A1 (fr) | 2014-10-08 | 2016-04-14 | Pfizer Inc. | Composés d'amide substitué |
EP3911648A4 (fr) | 2019-01-18 | 2022-10-26 | Astrazeneca AB | Inhibiteurs de pcsk9 et leurs procédés d'utilisation |
Family Cites Families (18)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3178418A (en) | 1963-02-26 | 1965-04-13 | Glaxo Lab Ltd | Monobromination at the 11-position of hecogenin and 3-lower alkanoyl esters thereof |
DE2926463A1 (de) * | 1978-07-05 | 1980-01-24 | Roecar Holdings Nv | Spiroketaline und ihre verwendung |
US4260603A (en) | 1979-01-02 | 1981-04-07 | Pegel Karl H | Sterol glycoside with activity as prostaglandin synthetase inhibitor |
NZ193564A (en) * | 1979-05-02 | 1985-01-31 | Aruba Pty Ltd | Steroid alkaloids from solanum sodomeum and pharmaceutical compositions |
US4602003A (en) | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Synthetic compounds to inhibit intestinal absorption of cholesterol in the treatment of hypercholesterolemia |
US4602005A (en) | 1982-05-17 | 1986-07-22 | Medical Research Foundation Of Oregon | Tigogenin cellobioside for treating hypercholesterolemia and atherosclerosis |
ES524614A0 (es) * | 1982-08-12 | 1984-05-01 | Nativelle Sa Ets | Procedimiento de preparacion de nuevos amino-14 esteroides. |
ES524796A0 (es) * | 1982-08-20 | 1984-05-01 | Nativelle Sa Ets | Procedimiento de preparacion de nuevos derivos de amino-14 esteroides |
IT1188184B (it) | 1985-08-14 | 1988-01-07 | Texcontor Ets | Sali ammonici quaternari di polisaccaridi ad attivita' ipocolesterolemizzante |
US5017562A (en) * | 1987-02-11 | 1991-05-21 | Regents Of The University Of Minnesota | Crystalline saponin-containing complex |
FR2621316B1 (fr) * | 1987-10-02 | 1991-06-21 | Nativelle Sa Ets | Nouveaux esters d'acide androstane 17-carboxylique, procede pour leur preparation, et medicament les contenant |
US5010185A (en) * | 1989-06-13 | 1991-04-23 | Pfizer Inc. | Processes for tigogenin beta-cellobioside |
DE69222532T2 (de) * | 1991-07-23 | 1998-02-26 | Schering Corp | Substituierte beta-lactam-verbindungen als hypocholesterolemische mittel und verfahren zu deren herstellung |
WO1993005790A1 (fr) * | 1991-09-27 | 1993-04-01 | Procter & Gamble Pharmaceuticals, Inc. | Emploi de 14-aminosteroides dans la fabrication d'un medicament destine a ralentir la vitesse de progression d'alterations structurelles myocardiques caracteristique de l'insuffisance cardiaque congestive |
WO1993007167A1 (fr) * | 1991-10-04 | 1993-04-15 | The Procter & Gamble Company | Composes d'abaissement du taux de cholesterol et leur procede de production |
AU659506B2 (en) * | 1991-11-25 | 1995-05-18 | Pfizer Inc. | Method for making steroidal peracyl glycosides |
US5530107A (en) * | 1992-10-15 | 1996-06-25 | Pfizer Inc. | Method for making steroidal peracyl glycosides |
LT3595B (en) * | 1993-01-21 | 1995-12-27 | Schering Corp | Spirocycloalkyl-substituted azetidinones useful as hypocholesterolemic agents |
-
1993
- 1993-05-06 CZ CZ943310A patent/CZ331094A3/cs unknown
- 1993-05-06 RU RU94046294/04A patent/RU94046294A/ru unknown
- 1993-05-06 EP EP97200456A patent/EP0796864A2/fr not_active Withdrawn
- 1993-05-06 BR BR9306619A patent/BR9306619A/pt not_active Application Discontinuation
- 1993-05-06 EP EP97200455A patent/EP0796863A2/fr not_active Withdrawn
- 1993-05-06 EP EP93910951A patent/EP0647234A1/fr not_active Withdrawn
- 1993-05-06 EP EP97200454A patent/EP0796862A2/fr not_active Withdrawn
- 1993-05-06 WO PCT/US1993/004092 patent/WO1994000480A1/fr not_active Application Discontinuation
- 1993-05-06 AU AU42265/93A patent/AU4226593A/en not_active Abandoned
- 1993-05-06 CA CA002139104A patent/CA2139104A1/fr not_active Abandoned
- 1993-05-06 US US08/351,470 patent/US5629295A/en not_active Expired - Fee Related
- 1993-05-06 JP JP6502331A patent/JPH07504921A/ja active Pending
- 1993-05-06 SK SK1583-94A patent/SK158394A3/sk unknown
- 1993-06-17 IL IL106055A patent/IL106055A0/xx unknown
- 1993-06-17 AP APAP/P/1993/000539A patent/AP489A/en active
- 1993-06-24 HR HR07/904,914A patent/HRP930994A2/xx not_active Application Discontinuation
- 1993-06-25 YU YU44793A patent/YU44793A/sh unknown
- 1993-06-25 CN CN93107620A patent/CN1085561A/zh active Pending
- 1993-06-25 MX MX9303826A patent/MX9303826A/es unknown
-
1994
- 1994-12-13 BG BG99261A patent/BG99261A/xx unknown
- 1994-12-23 OA OA60598A patent/OA10121A/en unknown
- 1994-12-24 KR KR1019940704728A patent/KR950702203A/ko not_active Application Discontinuation
-
1995
- 1995-06-06 US US08/470,554 patent/US5703052A/en not_active Expired - Fee Related
-
1997
- 1997-02-14 JP JP9030588A patent/JPH09309897A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
CN1085561A (zh) | 1994-04-20 |
BG99261A (en) | 1995-06-30 |
HRP930994A2 (en) | 1996-08-31 |
AP489A (en) | 1996-05-02 |
EP0647234A1 (fr) | 1995-04-12 |
EP0796863A2 (fr) | 1997-09-24 |
KR950702203A (ko) | 1995-06-19 |
WO1994000480A1 (fr) | 1994-01-06 |
AP9300539A0 (en) | 1993-07-31 |
BR9306619A (pt) | 1998-12-08 |
JPH09309897A (ja) | 1997-12-02 |
RU94046294A (ru) | 1996-10-10 |
YU44793A (sh) | 1996-10-09 |
MX9303826A (es) | 1994-02-28 |
AU4226593A (en) | 1994-01-24 |
EP0796862A2 (fr) | 1997-09-24 |
US5703052A (en) | 1997-12-30 |
IL106055A0 (en) | 1993-10-20 |
CZ331094A3 (en) | 1995-09-13 |
SK158394A3 (en) | 1995-05-10 |
CA2139104A1 (fr) | 1994-01-06 |
US5629295A (en) | 1997-05-13 |
EP0796864A2 (fr) | 1997-09-24 |
JPH07504921A (ja) | 1995-06-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
OA10121A (en) | Steroidal glycosides for treating hypercholesterolemia | |
GB1599863A (en) | Pharmaceutical compositions for use in the inhibition of the biosynthesis of mevalonic acid | |
KR970002642B1 (ko) | 안드로스탄 17-카복실산 에스테르, 이의 제조방법, 및 이를 함유하는 약제 | |
AP518A (en) | Spirostanyl glycosidal crystalline monohydrate. | |
JPS596880B2 (ja) | D−ホモステロイドの製造方法 | |
US5939398A (en) | Hypocholesterolemic agents | |
JPS5967298A (ja) | 新規6.16―ジメチルコルチコイド及びその製法 | |
US6150336A (en) | Steroidal glycosides | |
EP0737203A1 (fr) | Glycosides steroidiens | |
GB2130587A (en) | Novel 6a-methylcorticoids and their manufacture and use | |
EP0072546B1 (fr) | Dérivés d'hydrocortisone, leur préparation et leur utilisation | |
US4260464A (en) | Process for the preparation of 17α-(3-iodobenzoyloxy)-9α-chloro-4-pregnene-3,20-diones and their D-homo homologs | |
EP0778846A1 (fr) | Cristaux de spirostanyl glycosidal | |
DD208812A5 (de) | Verfahren zur herstellung von 6-alpha-methylhydrocortison-derivaten | |
Peters et al. | Steroidal silicon side-chain analogs as potential antifertility agents | |
US4353898A (en) | 11α-Amino-androstanes | |
NO945001L (no) | Steroide glykosider for behandling av hyperkolestrolemi | |
EP0430386A1 (fr) | 14Alpha, 17alpha portés-16-hydroxyestratriènes | |
Orr et al. | Steroids. CCVII. Ring A Modified Hormone Analogs. Part III. 1 2-Formyl-Δ2-androstenes and Related Compounds. A New Class of Potent Anabolic Agents2 | |
US2793208A (en) | Organic compounds | |
US4127589A (en) | 4,5-Seco-steroids | |
JPS635097A (ja) | アンドロスト−4−エン−3,17−ジオンのメチレン誘導体およびその製造方法 | |
IL26262A (en) | 5beta-h-6-keto-steroids,their preparation and pharmaceutical compositions containing them |